We may earn a commission from providers listed here, which can affect where they appear but never our ratings or reviews.
TopWeightLoss.us
Science6 min read

How Do GLP-1 Medications Work for Weight Loss?

GLP-1 drugs copy a gut hormone that signals fullness. How semaglutide and tirzepatide cut appetite, steady blood sugar and drove 15-22.5% trial weight loss.

Last updated September 15, 2026

Francheska Capistrano, Medical Content Reviewer

Francheska Capistrano, RMT, MPH

Clinically checked · Our review process

Key points

  • A GLP-1 medication imitates a hormone your gut releases after meals: it slows how fast the stomach empties and tells the brain you are full, which quiets "food noise". The effect is chemical, not a test of willpower.
  • GLP-1s also raise insulin when blood glucose is high, smoothing out the sugar spikes and dips that tend to set off cravings.
  • Tirzepatide acts on a second receptor (GIP). Trial averages: about 15% body-weight loss for semaglutide (STEP) and up to ~22.5% for tirzepatide (SURMOUNT), over 68-72 weeks.
  • Most people feel appetite shift within two weeks and see visible loss around weeks 4-8. Stomach side effects are strongest right after dose increases and usually settle.

What is a GLP-1 medication?

A GLP-1 medication is a prescription drug that mimics glucagon-like peptide-1, a hormone your intestines release after you eat. The class, called GLP-1 receptor agonists, was first developed to treat type 2 diabetes.
  • Semaglutide is the active ingredient in Ozempic and Wegovy.
  • Tirzepatide is the active ingredient in Mounjaro and Zepbound.
Strong clinical trial results for weight management led the FDA to approve these drugs specifically for weight loss.

Our 2 favorite GLP-1 providers

The two providers our editors recommend first, with the same checked prices and scores used in our full ranking.

Our Most Popular
1
embody logo

Exceptional

9.8out of 10

Semaglutide from $69/mo, delivered in 1-2 days

Refund if not approvedFree expedited shipping

Treatments offered

Compounded semaglutide injection (GLP-1) · Compounded tirzepatide injection (GLP-1 + GIP) · Online doctor review and prescription · Dose changes through the patient portal

Starting price

$79$69/month

*Compounded medications are not FDA-approved.

  • Semaglutide $69/mo; tirzepatide $119/mo
  • 5-minute questionnaire; doctor review usually within 24 hours
  • Free 1-2 day shipping: cold-packed, tracked and insured
  • No insurance, no clinic visits, cancel anytime

from $69/month

Visit SiteRead full review
3.8Trustpilot(9,604)

embody prescribes compounded semaglutide at $69/mo and tirzepatide at $119/mo online, ships in 1-2 days, and requires no insurance. Trustpilot: 3.8 from 9,604 reviews.

Read full embody review
2
altRx logo

Exceptional

9.7out of 10

Low-cost GLP-1 care: semaglutide from $89/mo

Clear, flat pricingNo insurance needed

Treatments offered

Compounded semaglutide injection (GLP-1) · Compounded tirzepatide injection (GLP-1 + GIP) · Brand-name Ozempic, Zepbound and Wegovy · Once-weekly injection schedule

Starting price

$199$89/month

*Compounded medications are not FDA-approved.

  • Semaglutide from $89/mo; tirzepatide from $149/mo
  • Brand-name Ozempic, Zepbound and Wegovy available
  • Reviewed by a physician, PA or nurse practitioner
  • Free shipping, arriving in about 5-7 days

from $89/month

altRx sells compounded semaglutide from $89/month and tirzepatide from $149/month at a flat price per dose, plus brand-name Ozempic, Zepbound and Wegovy. Self-pay, no insurance needed.

Read full altRx review

Why do GLP-1 drugs make you feel less hungry?

GLP-1 drugs reduce hunger by acting on brain receptors that control appetite and fullness, and by keeping food in the stomach longer. Slower gastric emptying means a meal satisfies you for more hours, while the brain receives a steady "you are full" signal.

Patients often say the drug turns down "food noise": the running background thoughts about snacks and the next meal that make dieting so draining. That change comes from biochemistry, not from trying harder.

What do GLP-1s do to blood sugar and insulin?

GLP-1 medications help control blood sugar in two ways: they prompt the pancreas to release insulin when glucose is elevated, and they lower glucagon output. Together, these effects flatten the blood sugar swings that commonly lead to cravings and overeating.

This matters most for people with insulin resistance, a frequent contributor to weight gain, because the medication works directly on that problem.

Lowest-priced GLP-1 plans

The cheapest published plans, sorted from lowest price, with the terms listed under every price.

What makes tirzepatide different from semaglutide?

Tirzepatide is a dual agonist: it activates the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, while semaglutide activates GLP-1 alone. The added GIP activity brings extra metabolic effects that work alongside the GLP-1 pathway.

In clinical trials, this two-receptor approach produced even larger weight loss, with some participants losing more than 20% of their body weight. Our tirzepatide vs semaglutide comparison covers the differences in detail.

Is GLP-1 Treatment Right for You?

GLP-1 medication is prescription-only: a licensed clinician has to decide it is appropriate, and it is not a fit for everyone. Side effects are possible, and they tend to show up in the first few weeks while your body adapts.

Results are usually best when the medication is paired with simple daily habits, such as balanced meals and regular movement.

For both safety and lasting progress, pick a provider that screens you properly before prescribing and keeps following up once treatment starts.

Woman getting a GLP-1 weight loss injection pen ready

How much weight do people lose on GLP-1 medication?

In large trials, people lost an average of about 15% of body weight on semaglutide (STEP trials) and up to ~22.5% on tirzepatide (SURMOUNT trials) over 68-72 weeks. Individual results vary a lot.
  • Weeks 1-2: most people notice appetite changes.
  • Weeks 4-8: weight loss usually becomes visible.
  • Dosing: one injection a week, with the dose raised step by step over several months to limit side effects.
For a week-by-week view of the start of treatment, see your first month on weight loss medication.

What side effects do GLP-1 medications cause?

The side effects people report most are digestive: nausea, vomiting, diarrhea and constipation. They tend to peak right after a dose increase and fade as the body adapts, which is why starting low and titrating slowly works for most patients.

Rarer but more serious risks include pancreatitis and gallbladder problems, so treatment should always be medically supervised. Our semaglutide side effects guide covers how to manage them, and our matching quiz can point you to a provider with strong clinical oversight.

Which weight loss provider fits you best?

Our ranking compares the leading providers on price, clinical support and medication choices.

Popular provider matchups

Side-by-side comparisons with checked prices, the ones readers rely on most when choosing.

References and clinical sources

The medication facts on this page rest on FDA guidance and peer-reviewed clinical trials, while prices and plan terms come from what each provider publishes. Use this page as general information, not medical advice, and speak with a licensed clinician before you start any weight loss treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)